What it is
The stem cells sold by longevity and orthopaedic clinics are almost always mesenchymal stem cells (MSCs, more accurately "mesenchymal stromal cells"): cells from bone marrow, fat or umbilical-cord tissue that can become bone, cartilage or fat in a dish and that, in the body, mostly act by secreting signals that calm inflammation and recruit repair. They are not embryonic stem cells and they do not turn into new cartilage in your knee in any meaningful quantity — the "regeneration" is a signalling effect, which is also why the exosome field exists.
- Autologous — your own cells. Bone-marrow aspirate concentrate (BMAC) from the hip, or the stromal vascular fraction (SVF) from liposuctioned fat, prepared the same day and reinjected. No immune mismatch; the cell count is low and falls with age.
- Allogeneic — donor cells, usually umbilical cord or placenta, expanded in culture to large numbers and frozen. Consistent dose, available at any age, but a manufactured biological product that needs the oversight of one.
- Culture-expanded autologous — your cells, grown for weeks to raise the count. The most studied form in trials and the least available outside them.
What the research says
| Use | Evidence grade | What was found |
|---|---|---|
| Graft-versus-host disease (after bone-marrow transplant) | Strong — approved products in several countries | Reduces mortality in steroid-resistant disease. The proof that MSCs work as immune modulators in people. |
| Perianal fistulas in Crohn's disease | Strong — phase 3 RCT, product approval in some jurisdictions | Higher remission at 24 weeks than placebo. A specific, local, inflammatory use. |
| Knee osteoarthritis | Moderate / mixed — many small RCTs, several meta-analyses | Pain and function scores improve modestly for 6–12 months, comparable to or slightly better than hyaluronic acid. Imaging rarely shows new cartilage. Trials differ so much in cell source and dose that pooling them is questionable. |
| Tendon and rotator cuff repair | Early — small trials | Some reduction in re-tear rates when added to surgery; little evidence as a stand-alone injection. |
| Systemic inflammation, frailty, "ageing" | Early — one phase 2 (allogeneic MSCs in frail older adults, Tompkins 2017), small numbers | Improved walking distance and lowered TNF-α at six months. Interesting; unreplicated; no lifespan or disease outcome. |
| Autism, multiple sclerosis, ALS, Parkinson's as sold by clinics | Hype | Trials exist and are mostly negative or inconclusive. Clinics selling these are selling hope. |
Protocols that are studied
- Knee osteoarthritis. A single intra-articular injection of 10–100 million culture-expanded MSCs, or BMAC/SVF prepared the same day (typically far fewer true stem cells). Follow-up 6–24 months. Higher cell counts have not reliably outperformed lower ones.
- Frailty. One intravenous infusion of 100 million allogeneic MSCs in the phase 2 trial.
- Inflammatory bowel fistulas. 120 million cells injected around the fistula tract, once.
- What clinics sell. Often multiple IV infusions of umbilical-cord MSCs, sometimes combined with joint injections, with no published protocol behind the package.
Costs reported by clients range from about €3,000 for a same-day BMAC knee injection to €25,000–60,000 for multi-infusion packages abroad. Against a modest 6–12-month improvement in knee pain that a physiotherapy block, weight loss and PRP can approach for a fraction of the price, the arithmetic is unflattering for most people.
Who it suits — and who should avoid it
The reasonable candidate is someone with moderate knee osteoarthritis who has already done the rehabilitation, is not ready for a replacement, understands the effect is temporary, and is treated by an orthopaedic physician within a regulated framework or a registered trial. For a healthy adult seeking "longevity", there is no evidence that justifies the cost or the risk.
Avoid
- Any history of cancer — MSCs secrete growth factors; every trial excludes it.
- Active infection, pregnancy, uncontrolled diabetes, anticoagulation that cannot be paused for a procedure.
- Intravenous donor cells outside a regulated setting. Documented harms include infection from contaminated products, pulmonary embolism and, in a few reported cases, tumours at injection sites.
- Any clinic that treats a list of unrelated conditions with the same product.
Regulation, by region
- United States. Same-day, minimally manipulated autologous cells used for the same function they came from are exempt from drug approval; culture-expanded or donor cells are biologics that need a licence, and the regulator has pursued clinics ignoring that line.
- European Union and United Kingdom. Expanded or donor cells are advanced-therapy medicinal products and need marketing authorisation or a hospital exemption; a handful of products are authorised, none for "longevity".
- Switzerland, UAE, Hungary. Broadly aligned with the EU model; licensed hospitals may use authorised products or run trials. Wellness clinics generally may not.
- Mexico, Panama, Caribbean, parts of Asia. Lighter oversight. This is where the IV packages are sold, and where product quality is hardest to verify.
Where it fits in a personal protocol
Rarely, and never first. A protocol for a joint or recovery goal puts training modification, load management, body composition and the labs ahead of any injection, then the compounds studied for soft-tissue repair — BPC-157, TB-500 — and the therapies with trial data, which for a knee means PRP before cells. If a client is set on a stem-cell procedure, the physician copy notes it so their doctor can advise on the setting, and a coach can time the training block around the recovery weeks. Longevity Bros does not arrange, provide or refer for stem-cell procedures. The immune and inflammation page shows the layers a regenerative goal is built from.
The hype vs the evidence
- "Regrows cartilage." Imaging in the trials mostly does not show it. The benefit, where present, is reduced pain and inflammation for a season.
- "Younger cells are better, so use cord cells." Plausible, unproven, and it moves you from an exempt procedure to an unlicensed biologic.
- "Reverses ageing systemically." One small frailty trial with a six-month walking-test result. Nothing more.
- What is real: immune-modulation in transplant disease, fistula closure, and a modest, temporary effect on knee pain in a regulated orthopaedic setting.
Frequently asked questions
Which questions should I ask a stem-cell clinic?
Which cells, from where, how many, and how was the count verified? Is the product licensed or the procedure in a registered trial? What does the published evidence say for my exact condition? What is the adverse-event rate at this clinic and who follows up? If the answers are vague, leave.
Autologous or donor cells?
Autologous same-day preparations are legal in more places and carry no immune or infection-transfer risk, but contain few true stem cells. Donor cells give a consistent dose but are manufactured biologics that need proper licensing. Neither has shown a clear advantage in knee trials.
How long does a knee injection last?
In the trials, improvements in pain and function are reported for six to twelve months, occasionally two years. The structural change on MRI is small or absent.
Is stem-cell therapy worth it for longevity?
Not on current evidence. There is no trial showing that MSCs extend health or life in healthy adults, and the frailty study that gets cited was small and short. The money moves far more in training, sleep, labs and body composition.
Does Longevity Bros provide or arrange stem-cell therapy?
No. We write research protocols and coach. If you are considering a procedure, your protocol gives you the evidence and the questions above to take to your physician, who decides whether a regulated route exists for you.
Want these built into a plan for you?
If a regenerative therapy is part of your goal, the protocol lays out what the evidence supports, what it does not, and the questions to take to a physician before any clinic visit. €399, follow-up included.
Build my protocol Book a 15-minute call